FDA Acceptance of Supplement for GLUMETZA by Santarus Inc.
The FDA has accepted a supplemental application for GLUMETZA (metformin hydrochloride) submitted by Santarus Inc.
Asset / Drug
Drug and asset intelligence for GLUMETZA with 1 indexed intelligence signal across regulatory, clinical, competitive, and market developments.
No catalysts indexed for this entity yet.
No catalysts indexed for this entity yet.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.